Clinical Trials Browser

Phase 2 × Has results × quizartinib × Clear all

NCT04209725 2023-12-05

A Study of CPX-351 (Vyxeos™) With Quizartinib for the Treatment of FLT3-ITD Mutation-Positive Acute Myeloid Leukemia

Phase 2 Terminated

1 enrolled 7 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02984995 2020-02-17

Phase 2 Study of Quizartinib in Participants With Acute Myeloid Leukemia (AML) FLT3 Internal Tandem Duplication (FLT3/ITD) Mutation

Phase 2 Completed

37 enrolled 24 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01565668 2019-12-27

Open Label Study to Evaluate Safety and Efficacy of 2 Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase 2 Completed

76 enrolled 17 charts

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

NCT00989261 2019-12-11

ACE

Phase 2 Completed

333 enrolled 23 charts

Other hematologic neoplasm

Leukemia, Recurrence, Leukemia, Myeloid, Acute